Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Sanofi Consumer Healthcare India

Market Cap: ₹107.0b

Operates as a fast-moving consumer healthcare company in India.

ALTEOGEN

Market Cap: ₩20.3t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Sanofi India

Market Cap: ₹79.1b

Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹414.2b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

Pharma Mar

Market Cap: €1.6b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.

Abbott India

Market Cap: ₹540.8b

Operates as a pharmaceutical company in India.

Highnoon Laboratories

Market Cap: PK₨51.0b

Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.

GlaxoSmithKline Pakistan

Market Cap: PK₨115.7b

Operates as a biopharma company in Pakistan.

Exelixis

Market Cap: US$11.4b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Consun Pharmaceutical Group

Market Cap: HK$13.2b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

Rigel Pharmaceuticals

Market Cap: US$559.8m

A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.

Chugai Pharmaceutical

Market Cap: JP¥12.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥41.0b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

Gubra

Market Cap: DKK 5.2b

A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.

Blue Jet Healthcare

Market Cap: ₹77.0b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.